Search

agbiopro
- Apr 23, 2019
- 0 min read

AbbVie puts up $105M for Tizona's preclinical I/O drug

Recent Posts

ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing

GentiBio Launches with $20 Million Seed Funding from Novartis and Others

Kymera Therapeutics Unveils IPO Pitch for Protein Degradation